These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 4071749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

  • 7. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

  • 8. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W.
    Przegl Epidemiol; 1993 Jul; 47(1-2):47-53. PubMed ID: 8351387
    [Abstract] [Full Text] [Related]

  • 9. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mumps and rubella consensus conference.
    Can Commun Dis Rep; 1994 Oct 15; 20(19):165-76. PubMed ID: 7804152
    [No Abstract] [Full Text] [Related]

  • 14. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A, Giorgi-Rossi P, Sangalli M, Spadea T, Perucci CA.
    Ann Ig; 2002 Oct 15; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The impact of MMR vaccine on mumps infection in England and Wales.
    Jones AG, White JM, Begg NT.
    CDR (Lond Engl Rev); 1991 Aug 16; 1(9):R93-6. PubMed ID: 1669792
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of the coverage by the measles-rubella-mumps vaccine in the Rhône district].
    Van Gioi N.
    Pediatrie; 1991 Aug 16; 46(10):699. PubMed ID: 1662359
    [No Abstract] [Full Text] [Related]

  • 19. [Conjugated vaccine against measles, rubella and mumps].
    Vopr Virusol; 1989 Aug 16; 34(1):117-9. PubMed ID: 2728403
    [No Abstract] [Full Text] [Related]

  • 20. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE, Buynak EB, Stokes J, Hilleman MR.
    Pediatrics; 1973 Mar 16; 51(3):467-75. PubMed ID: 4707864
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.